Serum Adipokines Associated With Diabetic Risk Factors
|
By LabMedica International staff writers Posted on 10 Jan 2012 |
|
Cytokines produced by the adipose tissue are known as adipokines and abnormal levels in the serum maybe cardiovascular risk factors for diabetic patients.
The relationship of the serum profile of adipokines, such as leptin, adiponectin, resistin, and interleukin 6 (IL-6) has been evaluated with these risk factors for obese patients with diabetes mellitus type 2 (DM2).
In a prospective study at the University of Valladolid (Spain), 108 obese patients with DM2 were enrolled and their blood was analyzed. A complete biochemical, anthropometric, and nutritional evaluation was performed. Basal glucose, C-reactive protein (CRP), insulin, total cholesterol, low-density lipoprotein (LDL)-cholesterol, high-density liporotein (HDL)-cholesterol, triglycerides blood, and adipokines (leptin, adiponectin, resistin, and IL-6) levels were measured in fasting condition.
Interleukin 6 was measured by an enzyme-linked immunosorbent assay ELISA (R&D systems, Inc.; Minneapolis, MN, USA) with a sensitivity of 0.5 pg/mL. Normal values of IL6 were 1.12-12.5 pg/mL. Adiponectin was measured by an ELISA, also from R&D systems, with a sensitivity of 0.246 ng/mL and a normal range of 865-21,424 ng/mL. Resistin was measured by an ELISA (Biovendor Laboratory, Inc.; Brno, Czech Republic) with a sensitivity of 0.2 ng/mL and a normal range of 4-12 ng/mL. Leptin was measured by ELISA (Diagnostic Systems Laboratories, Inc.; Webster, TX, USA) with a sensitivity of 0.05ng/mL and a normal range of 10-100 ng/mL.
The authors concluded that the serum profile of adipokines is related with different cardiovascular risk factors and anthropometrical variables in obese patients with diabetes type 2. The serum profile of the adipokines showed that only leptin levels were higher in women than in men. These associations have different implications with each adipokine and each parameter was shown by multivariate analysis. The study was published in the November 2011 issue of Journal of Clinical Laboratory Analysis .
Related Links:
University of Valladolid
R&D systems
Biovendor Laboratory
The relationship of the serum profile of adipokines, such as leptin, adiponectin, resistin, and interleukin 6 (IL-6) has been evaluated with these risk factors for obese patients with diabetes mellitus type 2 (DM2).
In a prospective study at the University of Valladolid (Spain), 108 obese patients with DM2 were enrolled and their blood was analyzed. A complete biochemical, anthropometric, and nutritional evaluation was performed. Basal glucose, C-reactive protein (CRP), insulin, total cholesterol, low-density lipoprotein (LDL)-cholesterol, high-density liporotein (HDL)-cholesterol, triglycerides blood, and adipokines (leptin, adiponectin, resistin, and IL-6) levels were measured in fasting condition.
Interleukin 6 was measured by an enzyme-linked immunosorbent assay ELISA (R&D systems, Inc.; Minneapolis, MN, USA) with a sensitivity of 0.5 pg/mL. Normal values of IL6 were 1.12-12.5 pg/mL. Adiponectin was measured by an ELISA, also from R&D systems, with a sensitivity of 0.246 ng/mL and a normal range of 865-21,424 ng/mL. Resistin was measured by an ELISA (Biovendor Laboratory, Inc.; Brno, Czech Republic) with a sensitivity of 0.2 ng/mL and a normal range of 4-12 ng/mL. Leptin was measured by ELISA (Diagnostic Systems Laboratories, Inc.; Webster, TX, USA) with a sensitivity of 0.05ng/mL and a normal range of 10-100 ng/mL.
The authors concluded that the serum profile of adipokines is related with different cardiovascular risk factors and anthropometrical variables in obese patients with diabetes type 2. The serum profile of the adipokines showed that only leptin levels were higher in women than in men. These associations have different implications with each adipokine and each parameter was shown by multivariate analysis. The study was published in the November 2011 issue of Journal of Clinical Laboratory Analysis .
Related Links:
University of Valladolid
R&D systems
Biovendor Laboratory
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Immunofluorescence Analyzer
IFA System
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Latest Immunology News
- Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
- Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
- Study Points to Autoimmune Pathway Behind Long COVID Symptoms
- Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease
- Simple Blood Test Could Replace Biopsies for Lung Transplant Rejection Monitoring
- Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
- Biomarkers and Molecular Testing Advance Precision Allergy Care
- Point-of-Care Tests Could Expand Access to Mpox Diagnosis
- T-Cell Senescence Profiling May Predict CAR T Responses
- Finger-Prick Lateral Flow Test Detects Sepsis Biomarkers at Point of Care
- Study Highlights Low Sensitivity of Current Lyme Tests in Early Infection
- Immune Aging Clock Quantifies Immunosenescence and Identifies Therapeutic Target
- Study Finds Influenza Often Undiagnosed in Winter Deaths
- Combined Screening Approach Identifies Early Leprosy Cases
- Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
- FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Channels
Molecular Diagnostics
view channel
Blood Test Predicts Immunotherapy Response in Head and Neck Cancer
Head and neck squamous cell carcinoma affects hundreds of thousands of people worldwide each year, yet response rates to immunotherapy remain low. Clinicians lack reliable, minimally invasive tools to... Read more
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Hematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read more
Immunology
view channel
Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Microbiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read more
Pathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read more
Technology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read more
Industry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more
